Stock Performance and Market Context
On 9 Mar 2026, Zenith Health Care Ltd’s share price slipped to Rs.2.82, representing a fresh 52-week low. This decline occurred despite the stock outperforming its sector by 0.68% on the day. The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum.
The broader market environment has been challenging, with the Sensex opening sharply lower by 1,862.15 points and trading at 76,996.42, down 2.44%. The Sensex has experienced a three-week consecutive fall, losing 7.03% over this period. While the Sensex remains below its 50-day moving average, the 50DMA itself is positioned above the 200DMA, indicating some longer-term support for the benchmark index.
In contrast to Zenith Health Care’s decline, the INDIA VIX index hit a new 52-week high today, reflecting increased market volatility and investor caution.
Long-Term and Recent Performance Metrics
Over the past year, Zenith Health Care Ltd has delivered a negative return of -39.48%, significantly underperforming the Sensex, which posted a positive return of 3.58% during the same period. The stock’s 52-week high was Rs.5.30, highlighting the extent of the recent price erosion.
In addition to the one-year underperformance, the company has lagged behind the BSE500 index over the last three years, one year, and three months, indicating persistent challenges in maintaining competitive returns.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Financial Fundamentals and Valuation
Zenith Health Care Ltd’s financial fundamentals have been under pressure, contributing to its current valuation and market sentiment. The company’s long-term operating profit growth has contracted at a compound annual growth rate (CAGR) of -15.14% over the last five years, reflecting a decline in core profitability.
The firm’s ability to service its debt is notably weak, with an average EBIT to interest ratio of just 0.02, indicating minimal earnings before interest and taxes relative to interest expenses. This ratio suggests limited cushion to cover debt costs, which may weigh on financial stability.
Profitability metrics also remain subdued, with an average return on equity (ROE) of 2.44%, signalling low returns generated on shareholders’ funds. This figure contrasts with the sector’s typical profitability levels and highlights challenges in generating shareholder value.
Despite these concerns, the company reported some positive quarterly results in December 2025. The PBDIT (Profit Before Depreciation, Interest and Taxes) reached a quarterly high of Rs.0.27 crore, while profit before tax excluding other income (PBT less OI) was Rs.0.21 crore. The net profit after tax (PAT) for the quarter also hit a peak of Rs.0.22 crore.
Valuation metrics show the stock trading at a price-to-book value of 2.2, which is considered fair relative to its ROE of 6%. Furthermore, the stock is priced at a discount compared to its peers’ average historical valuations. The company’s PEG ratio stands at 0.2, reflecting the relationship between its price-to-earnings ratio and earnings growth rate.
Shareholding and Market Grade
The majority of Zenith Health Care Ltd’s shares are held by non-institutional investors, which may influence trading patterns and liquidity. The company’s market capitalisation grade is rated 4, indicating a relatively modest market cap within its sector.
On 19 Feb 2025, the company’s Mojo Grade was downgraded from Sell to Strong Sell, with a current Mojo Score of 26.0. This downgrade reflects deteriorating fundamentals and market sentiment, reinforcing the cautious stance on the stock’s outlook.
Holding Zenith Health Care Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Metrics
To summarise, Zenith Health Care Ltd’s stock has declined to Rs.2.82, its lowest level in the past 52 weeks, amid a challenging market backdrop and company-specific financial headwinds. The stock’s underperformance relative to the Sensex and its sector, combined with weak profitability and debt servicing capacity, have contributed to its current valuation and market grade.
While the company has reported some quarterly profit improvements and maintains a fair price-to-book valuation, the overall trend remains subdued with a negative five-year operating profit growth rate and a low return on equity. The stock’s trading below all major moving averages further underscores the prevailing downward momentum.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
